MarketCap
Facebook
X
TelegramQuarterly report 2024-Q1
added 05-17-2024
ThermoGenesis Holdings DSO Ratio 2011-2026 | THMO
Annual DSO Ratio ThermoGenesis Holdings
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 45.2 | 41.5 | 51.8 | 35.8 | 56.9 | 93 | 97 | 117 | 107 | 99.5 | 87.5 | 61.8 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 117 | 35.8 | 74.5 |
Quarterly DSO Ratio ThermoGenesis Holdings
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35 | - | 23.8 | 34.7 | 50 | - | 94.2 | 67.5 | 49.8 | - | 55.1 | 42.9 | 66.4 | - | 53.5 | 56.2 | 37.9 | - | 28.7 | 27.1 | 42.9 | - | 44.2 | 68.7 | 78.1 | - | 50.2 | 44 | 66 | 68.7 | 74.8 | 37.2 | 80.4 | 98.5 | 142 | 142 | 157 | 87.8 | 113 | 92.2 | 128 | 99.5 | 114 | 100 | 128 | 84.3 | 89.4 | 86.6 | 106 | 89.7 | 78.6 | 75.7 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 157 | 23.8 | 75.3 |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
40.7 | $ 2.11 | 8.21 % | $ 3.29 M |  USA |
 |
AdaptHealth Corp.
AHCO
|
43.8 | $ 10.42 | -1.65 % | $ 1.41 B | USA |
 |
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
746 | - | -26.83 % | $ 2.62 M | USA |
 |
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M |  China |
 |
Alphatec Holdings
ATEC
|
43.1 | $ 12.6 | 2.61 % | $ 1.89 B | USA |
 |
Butterfly Network
BFLY
|
76.1 | $ 3.91 | 2.62 % | $ 828 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
72 | $ 8.38 | -0.24 % | $ 602 M |  Israel |
 |
Aziyo Biologics
AZYO
|
59.5 | - | 1.37 % | $ 20.5 M | USA |
 |
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | USA |
 |
BIOLASE
BIOL
|
42 | - | -13.19 % | $ 166 K | USA |
 |
Boston Scientific Corporation
BSX
|
65.7 | $ 69.79 | 0.95 % | $ 103 B | USA |
 |
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | USA |
 |
EDAP TMS S.A.
EDAP
|
91.8 | $ 3.96 | 1.02 % | $ 148 M |  France |
 |
CONMED Corporation
CNMD
|
64.5 | $ 37.41 | 0.35 % | $ 1.16 B | USA |
 |
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | USA |
 |
Cytosorbents Corporation
CTSO
|
68.6 | $ 0.65 | -8.13 % | $ 35.4 M | USA |
 |
Cutera
CUTR
|
327 | - | -10.19 % | $ 1.99 M | USA |
 |
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | USA |
 |
Dynatronics Corporation
DYNT
|
41.6 | - | 14.99 % | $ 929 K | USA |
 |
ClearPoint Neuro
CLPT
|
46.1 | $ 11.03 | 2.22 % | $ 298 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | USA |
 |
Establishment Labs Holdings
ESTA
|
123 | $ 63.48 | 0.21 % | $ 1.88 B |  Costa-rica |
 |
Axonics Modulation Technologies
AXNX
|
49.2 | - | - | $ 3.31 B | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
120 | - | - | $ 111 M |  Canada |
 |
FONAR Corporation
FONR
|
237 | $ 18.42 | 0.22 % | $ 121 M | USA |
 |
InMode Ltd.
INMD
|
5.36 | $ 13.43 | -0.81 % | $ 868 M | Israel |
 |
GBS
GBS
|
61.2 | - | -0.57 % | $ 7.12 M | USA |
 |
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | USA |
 |
Abbott Laboratories
ABT
|
61.2 | $ 109.95 | 1.8 % | $ 191 B | USA |
 |
Delcath Systems
DCTH
|
48.5 | $ 9.81 | 3.81 % | $ 351 M | USA |
 |
Bio-Rad Laboratories
BIO
|
66.9 | $ 261.24 | -0.59 % | $ 7.37 B | USA |
 |
Helius Medical Technologies
HSDT
|
53.3 | $ 2.19 | 3.79 % | $ 1.33 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
60.3 | $ 9.01 | -2.49 % | $ 694 M | USA |
 |
AxoGen
AXGN
|
40.7 | $ 32.84 | 1.55 % | $ 1.51 B | USA |
 |
Align Technology
ALGN
|
86.7 | $ 169.45 | 3.18 % | $ 12.7 B | USA |
 |
Bruker Corporation
BRKR
|
57.3 | $ 32.76 | -2.93 % | $ 4.88 K | USA |
 |
IRIDEX Corporation
IRIX
|
45.6 | $ 1.33 | 2.31 % | $ 21.5 M | USA |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
Apyx Medical Corporation
APYX
|
111 | $ 3.67 | 1.1 % | $ 151 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
74.3 | $ 17.11 | -1.16 % | $ 401 M | USA |
 |
Integer Holdings Corporation
ITGR
|
58.2 | $ 84.12 | 1.34 % | $ 2.92 B | USA |
 |
Invacare Corporation
IVC
|
206 | - | - | $ 24.7 M | USA |
 |
Second Sight Medical Products
EYES
|
49.1 | - | -0.97 % | $ 54.4 M | USA |